Editor's key points † The optimum arterial pressure to maintain splanchnic perfusion during cardiopulmonary bypass is unknown. † These authors used norepinephrine to manipulate mean arterial pressure to 60-65 and 80-85 mm Hg. † Splanchnic oxygenation, acid-base balance, and cytokine release remained similar. † There was no advantage or disadvantage for splanchnic metabolic function in targeting a higher arterial pressure using norepinephrine.
Maintaining adequate mean arterial pressure (MAP) during cardiopulmonary bypass (CPB) is considered important because MAP is a key determinant of vital organ perfusion. 1 2 In this context, adequate splanchnic perfusion and oxygenation is believed to be particularly important. 2 This is because right heart cannulation is likely associated with a degree of splanchnic congestion; lack of pulsatile flow may further jeopardize the gut and liver blood flow, and gastrointestinal complications are relatively common and sometimes clinically important after cardiac surgery. 3 4 Moreover, splanchnic hypoperfusion and hypoxia may cause subclinical injury secondary to translocation of bacteria, endotoxin, or both from the splanchnic bed into the systemic circulation. 5 Such translocation may, in turn, contribute to systemic inflammation and infection, splanchnic cytokine release, and delayed recovery in ways that are not appreciated or detected clinically. Despite the above concerns, it is unclear what level of MAP might best maintain splanchnic perfusion at a given pump flow during CPB. This is because perfusion pressure can only be reliably increased by the administration of vasopressor drugs. Vasopressor drugs, in turn, may induce splanchnic vasoconstriction and decrease perfusion. 6 In particular, norepinephrine, probably the most commonly used vasopressor drug, has been reported to cause mesenteric vasoconstriction. 7 Thus, increasing MAP and perfusion pressure may such oxygenation. Whether the gains are greater than the losses or vice versa remains uncertain. Accordingly, we conducted an alternating treatment design over study where 16 patients were subjected to 30 min periods of lower, higher, and then lower arterial pressure during CBP. We evaluated oxygen saturation in the hepatic veins, trans-splanchnic acid -base and electrolyte balance, and trans-splanchnic cytokine release as markers of splanchnic well-being. We hypothesized that increasing MAP with norepinephrine might significantly decrease hepatic vein oxygen saturation and increase both trans-splanchnic acidification of blood and cytokine release.
Methods

Design overview
This study was an alternating treatment design, singlecentre, open-label, controlled trial. The Human Research Ethics Committee of the Austin Hospital approved this study (Austin Hospital HREC number: H99/00667). Written informed consent was obtained from each patient. The study is reported using the recommendations of the CONSORT statement 8 and was registered with the Australian and New Zealand Clinical Trial Registry (ACTRN12611001107910).
Setting and participants
We enrolled a cohort of patients who were undergoing elective or urgent cardiac surgery necessitating the use of CPB at a university tertiary referral hospital. Clinical practice was not changed or modified for the purpose of the study and followed the same standard protocols as previously described. 9 10 In brief, all preoperative medications were routinely omitted on the day of surgery. Aspirin was stopped 1 week before surgery. Angiotensinconverting enzyme inhibitors were withdrawn on hospital admission (generally 1 day before surgery). The surgical approach in all patients was by median sternotomy. 
Intervention
Cardiovascular monitoring for all patients included radial arterial cannulation and a thermodilution pulmonary artery catheter (Baxter-Edwards Oximetry TD Catheter 93A-741H, 7.5 F) inserted via the right internal jugular vein. After induction of anaesthesia, a hepatic venous catheter (BaxterEdwards Oximetry TD Catheter 93A-741H, 7.5 F) was inserted through the femoral vein using fluoroscopy. Fluoroscopy was repeated at the end of surgery to confirm that the hepatic venous catheter had remained in place during the study period. Baseline haemodynamic measurements were obtained. Blood was drawn from the arterial line and from the hepatic vein for the measurement of biochemistry, blood gases, and cytokines [interleukin (IL)-6 and IL -10] .
Once the patient was on CPB, a MAP of between 60 and 65 mm Hg was targeted using an infusion of norepinephrine. After 30 min at this target MAP, samples and haemodynamic measurements were obtained for repeat measurements. After obtaining the samples, MAP was increased using an infusion of norepinephrine to a value between 80 and 85 mm Hg. After 30 min at this increased MAP, all measurements were repeated. After the samples were obtained, the MAP was allowed to return to a target of 60-65 mm Hg. After 30 min at this lower MAP, measurements and sampling were repeated once more.
Outcome measures and follow-up
The primary study outcome measure was hepatic venous saturation. Secondary outcomes included trans-splanchnic changes in lactate levels, trans-splanchnic changes in pH, trans-splanchnic changes in other markers of metabolic acid-base status (base excess and bicarbonate), and transsplanchnic changes in IL-6 and IL-10 levels. Trans-splanchnic changes were calculated by subtracting the hepatic vein values of the relevant variables from their arterial values. A positive value indicated a trans-splanchnic increase (release) and a negative value trans-splanchnic decrease (removal).
Power of the study and statistical analysis
After log transformation of the data, this study had a .80% power to detect a difference between the low and high MAP period equal to the standard deviation at an a of 0.05. Continuous data were tested for normal distribution. Between-group comparisons for continuous data were performed with the use of the t-test or the Mann -Whitney U-test. One-way analysis of variance (ANOVA) and Friedman's ANOVA were used to assess change over time for parametric and non-parametric data, respectively. Correlation coefficients were calculated with the Spearman rank correlation test. All tests were two-tailed and we considered a P-value of ,0.05 to indicate statistical significance. We report values as means with standard deviation (SD) and mean difference, or medians with inter-quartile ranges (IQR) as appropriate. We performed analyses by using STATISTICA TM software, version 10 (StatSoft, Tulsa, OK, USA).
Results
The patient characteristics, medications, and details of surgery are given in Table 1 . The patients underwent coronary artery bypass and/or valve surgery on CPB. None of the patients had gastrointestinal complications after cardiac surgery until hospital discharge. All patients survived to hospital discharge.
Circulation
The three MAP targets were achieved in all patients during CPB [65 (4), 84 (4), and 64 (3) mm Hg, respectively; P,0.001] ( Table 2 ). The norepinephrine infusion rate increased during the higher MAP target and decreased again at the second lower MAP target (P,0.001). MAP correlated with the norepinephrine infusion rate (r¼0.56). Cardiac output on CBP was predetermined and was therefore unchanged, as was the mixed venous saturation and the veno-arterial CO 2 tension difference. Core temperature increased at the end of the last arterial pressure target period (P,0.01). There was no correlation between MAP and hepatic vein oxygen saturation during CPB (r¼ 20.02) (Fig. 1) . The correlation coefficient between temperature and hepatic vein oxygen saturation during CPB was r¼ 20.41 (Fig. 2) . Finally, there was no correlation between norepinephrine dose and hepatic vein oxygen saturation during CPB (r¼ 20.005).
Arterial blood biochemistry
Arterial pH levels decreased numerically at the higher arterial pressure target but increased again slightly by the second lower arterial pressure target (Table 3) . Magnesium concentrations increased during CPB (P,0.05) as did lactate and glucose levels (P,0.01 vs ,0.001). IL-6 and IL-10 also markedly increased during CPB (P,0.001 for both) and levels of these cytokines correlated with each other (r¼0.55).
Hepatic vein blood biochemistry
Hepatic vein O 2 saturation decreased with time during CPB independent of MAP (P,0.05) ( Table 4 ). Magnesium and phosphate levels increased during CPB (P,0.05 and ,0.01, respectively). Hepatic vein IL-6 and IL-10 also increased during CPB (P,0.001 for both).
Trans-splanchnic biochemistry
Trans-splanchnic fluxes are presented in Table 5 . Transsplanchnic oxygen tension, oxygen saturation, chloride levels, lactate, and IL-6 were higher in the arterial blood compared with hepatic venous blood (P,0.001 for all), while carbon dioxide tension, bicarbonate, base excess, glucose, and IL-10 were lower in arterial blood compared with hepatic venous blood (P,0.001 for all). Trans-splanchnic magnesium, phosphate, and lactate removal occurred during CPB and concomitant glucose release (P,0.05). Transsplanchnic alkalinization of pH also occurred during CPB (P,0.05) with pH correlating with trans-splanchnic lactate removal (r¼0.61). There was release of IL-10, which increased from baseline to the end of the CPB and during time on CPB (P,0.05 for both), while, in contrast, IL-6 was removed during CPB and this effect increased from baseline to the end of the CPB (P,0.01), but no differences were seen during CBP. All changes in trans-splanchnic fluxes of 
Discussion
In this pilot study, we found that the administration of norepinephrine to increase MAP from a value between 60 and 65 mm Hg to a value between 80 and 85 mm Hg did not affect hepatic venous oxygen saturation or trans-splanchnic oxygen extraction. However, with increasing time of bypass, hepatic vein saturation decreased with its decrease correlating with an increase in body temperature (re-warming). Additionally, lactate and magnesium levels increased systemically, despite continued splanchnic extraction and glucose levels also increased systemically aided by splanchnic release throughout CPB. Finally, IL-6 and IL-10 increased during CPB but with differential splanchnic handling characterized by IL-10 release and IL-6 removal. MAP is considered important for organ perfusion. 1 However, experimental and clinical data on the role of increasing MAP with vasopressors during CPB are conflicting, suggesting both unchanged or decreased oxygen delivery in the splanchnic bed. 9 11 12 Our findings suggest that maintaining a higher MAP target with vasopressor does not improve or worsen splanchnic oxygenation, acid -base regulation, or cytokine release. In fact, hepatic vein O 2 saturation decreased during CPB irrespective of adequate MAP, 13 a process correlated with increasing body temperature. A mismatch between oxygen delivery and increased oxygen consumption during re-warming may be in part responsible for such changes in hepatic venous saturation. 14 15 Decreased hepatic venous oxygen saturation would suggest limited oxygenation reserve during CPB. Yet, frank splanchnic ischaemia appears unlikely as fundamental functions were preserved, 16 glucose continued to be added to the systemic circulation (most likely due to splanchnic gluconeogenesis given simultaneous phosphate extraction), magnesium was removed, and lactate continued to be extracted despite increased arterial lactate levels. This latter effect has also been reported by others. 17 Of clinical relevance, trans-splanchnic lactate removal during CPB implies that the hyperlactataemia of CPB is likely due to lactate release from other organs.
18 Additionally, we also found that apart from a distinct increase in blood magnesium concentrations, electrolyte and acid-base status were unchanged during CPB. The increasing magnesium concentrations are probably due to systemic magnesium delivery via pump prime and cardioplegia solutions entering the circulation.
Finally, we found that the splanchnic circulation adds carbon dioxide, bicarbonate, glucose, and IL-10 to the systemic circulation, but removes oxygen, chloride, lactate, and IL-6 from the systemic circulation. Carbon dioxide and bicarbonate production, and oxygen consumption are consequences of cellular metabolism. 19 A decrease in chloride could be due to erythrocyte uptake due to the Hamburger shift. 20 Glucose contribution and lactate removal suggest intact metabolic liver function. 21 The changes in cytokines represent a complex balance. We found that IL-6 and IL-10 increased during CPB. Similar findings have been reported by others. 22 23 The inflammatory response during CPB could be induced by increasing endotoxin in the circulation. 9 Although the gut has been previously implicated as a locus of endotoxin during hypoperfusion, 24 this has not been a consistent finding in patients on CPB. 9 Furthermore, our data indicate trans-splanchnic IL-6 removal during CPB, a finding for which previous data are limited. In particular, it has been previously reported that the gut releases and the liver takes up IL-6 during anaesthesia 25 and that IL-6 uptake capacity by the liver determines net trans-splanchnic contribution of IL-6 to the systemic circulation. 25 On the other hand, trans-splanchnic IL-10 release is consistent with previous reports. 26 27 Given the pro-inflammatory role of IL-6 and the anti-inflammatory and immunosuppressant role of IL-10, 28 it appears that, in relation to these two key cytokines, the splanchnic circulation during CPB does not contribute to systemic inflammation but rather to counterinflammation as long as hepatic IL-6 clearance is maintained. Our data suggest that the trans-splanchnic balance between these cytokines was unaltered during CPB. This study reports the effects of increasing the MAP from the lower level still regarded as safe in cardiac surgery patients, 13 to levels closer to normal arterial pressure in awake patients with ischaemic heart disease. 29 Its strengths include detailed biochemical analysis, assessment of metabolic and cytokine response, and an alternating treatment design, which increased statistical power and minimized the need for more patients to receive invasive hepatic vein monitoring. Although it cannot be excluded that a higher or lower MAP, respectively, would have shown a difference, the interval between these arterial pressure targets is clinically relevant. 30 31 Increasing MAP required the use of norepinephrine, a vasopressor that could influence splanchnic blood flow. 32 Thus, the effects of increased splanchnic perfusion pressure could have been offset by splanchnic vasoconstriction. 33 However, it was precisely the balance between these two effects that was the target of our investigation. One clear limitation of this study is using the hepatic venous saturation as a marker of the splanchnic perfusion. The liver is both supplied with splanchnic post-capillary blood through the portal vein, but also with fully oxygenated blood from the hepatic artery. A decrease in splanchnic perfusion does not necessarily result in a decrease in hepatic venous saturation since hepatic arterial inflow will increase through the hepatic arterial buffer response. 34 35 Thus, hepatic venous saturation is a surrogate measure of the splanchnic perfusion influences and may under certain conditions not reflect the splanchnic perfusion. However, neither changes in hepatic venous saturation nor in other variables, such as trans-splanchnic lactate levels, suggest arterial pressure-dependent changes in splanchnic perfusion.
Other consequences of the study design relate to the features of the alternating treatment design, the order effect, and the washout concept. Since the same patients were exposed to both lower and higher MAP, the effects of the first, lower MAP could, in theory, have influenced the physiology of the patients for the remaining time on CBP. The other consequence of this study design is the concept of washout time. Although the half-life of norepinephrine is short and MAP changes are rapid, the effects of these two on the splanchnic circulation could be longer. In addition, it cannot be excluded that the 30 min at each MAP level offered too short a time for assessment. Also, between the last measurements, re-warming already started, resulting in a temperature increase. Such temperature increase could influence tissue oxygen consumption. However, since oxygen consumption was statistically unchanged during this period, this effect was probably of limited importance. Moreover, the study was conducted in 'on-pump' patients with mild hypothermia. Since core temperature influences oxygen consumption, our findings can only be applied to cardiac surgery patients with mild hypothermia. Finally, splanchnic oxygen extraction was measured globally, but the distribution of splanchnic blood during CPB may be heterogeneous from the gut to pancreas and from the spleen to liver. 14 36 Focal ischaemia, which causes local cell injury or dysfunction and later leads to gastrointestinal complications, cannot be identified when performing global assessments. Although this is not a randomized controlled study, these results imply that a MAP at 60-65 mm Hg has similar effects on splanchnic oxygenation, acid -base balance, or inflammatory response as a higher MAP of 80-85 mm Hg achieved by norepinephrine infusion. Thus, our study suggests that manipulation of arterial pressure within these values during CPB does not worsen or improve global splanchnic oxygenation or function. In addition, our study suggests that, under normal CPB circumstances, the splanchnic bed removes lactate and makes blood more alkaline, implying lactate release elsewhere. It also contributes to hyperglycaemia by probable gluconeogenesis-related glucose release. Finally, it acts as a regulator of the immune response during CPB by contributing to a more counter-inflammatory balance between IL-6 and IL-10.
Gastrointestinal complications represent a serious group of adverse outcome after cardiac surgery. Although these complications are multifactorial, future research could focus on identifying other approaches (pulsatile flow, splanchnic vasodilator drugs) directed at protecting splanchnic organs during CPB, especially during re-warming.
Conclusion
These data suggest that increasing MAP with norepinephrine does not affect splanchnic oxygenation, acid -base balance, and key aspects of the splanchnic inflammatory response during CPB. From the perspective of splanchnic function, a MAP target of 60 -65 or 80-85 mm Hg appears physiologically equivalent.
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